Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind crossover trial of MT-8554 in painful diabetic peripheral neuropathy with open-label pilot arm
2016-002571-10Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of elismetrep in diabetic polyneuropathy (DPN) and type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Mitsubishi Tanabe Pharma Corporation. Primary endpoint: Pilot Arm safety and tolerability. Started Apr 2017; status: completed.
02
Drugs
elismetrep
03
Conditions
diabetic polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2016-002571-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002571-10.